ANGLE Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| TMO | Thermo Fisher Scientific | Outperform |
10
|
$577.93 | $591.94 | 7.28% | 1 | $218.97B |
| ROG | Roche Holding | Hold |
16
|
CHF222.30 | CHF307.83 | 22.58% | 9 | CHF179.41B |
| ILMN | Illumina | Outperform |
16
|
$110.62 | $159.28 | 33.34% | 9 | $17.62B |
| NTRA | Natera | Buy |
7
|
$95.66 | $74.41 | 8.20% | 8 | $11.69B |
| 6869 | Sysmex | Outperform |
18
|
¥7.99k | ¥8.90k | 11.40% | 0 | ¥1.74T |
| QGEN | QIAGEN N.V. | Outperform |
15
|
$42.94 | $0.00 | 16.44% | 3 | $9.53B |
| GH | Guardant Health | Buy |
6
|
$18.64 | $43.00 | 136.05% | 2 | $2.30B |
| NEO | NeoGenomics | Outperform |
8
|
$15.13 | $20.09 | 25.58% | 9 | $1.95B |
| ATOS | Atossa Genetics Inc | Buy |
5
|
$1.68 | $4.83 | 138.10% | 0 | $219.28M |
| 8YY | Biolidics | - |
-13
|
$0.01 | $0.00 | -100.00% | 0 | $53.09M |
| NVTA | Invitae | - |
4
|
$0.00 | $0.71 | 0.00% | 8 | $3.18M |
| BIOC.Q | Biocept | Hold |
-16
|
$0.00 | $8.00 | 0.00% | 0 | $0.13M |